A formulation combining a plant-derived Lactobacillus plantarum strain with a human-derived Lactobacillus fermentum strain ...

The therapeutic options for patients with inflammatory bowel disease (IBD) have recently expanded substantially. Tofacitinib, ...

Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for ...

Week 12 clinical remission of 23.1% (3/13) in higher-dose Cohort 2 vs. 11.4% (4/35) in lower-dose Cohort 138.9% ...

One-year results from SHINE-2 in children and adolescents with ulcerative colitis Of the patients enrolled in SHINE-2, 81% achieved clinical response at Week 12. Among responders, ages 6 to 17, ...

Coffee enemas are a form of so-called alternative medicine (SCAM) promoted by some practitioners and celebrities without credible scientific evidence. Their use is associated with several adverse ...

Multi-omics study reveals how myeloid-derived IL6/JAK/STAT3 signaling creates a spatially organized immunosuppressive niche ...

AbbVie's leadership in Inflammatory Bowel Disease (IBD) research programs Latest long-term and real-world data with ...

Comprehensive disease control was evaluated in a post hoc analysis at one year in patients with UC who responded to Omvoh at Week 12 in the LUCENT-1 induction study and were re-randomized in LUCENT-2 ...

Creatine, a popular dietary supplement, prevented brain inflammation, nerve cell damage, and disrupted electrical activity in ...

Inc. today announced that two analyses evaluating ZYMFENTRA® (infliximab-dyyb) will be presented in oral presentations on ...